Skip to main content
. 2008 Apr 8;12(4):1395–1403. doi: 10.1111/j.1582-4934.2008.00332.x

Fig. 4.

Fig. 4

Cell viability following 30 min. of hypoxia and 30 min. of reoxygenation in murine ventricular cardiomyocytes treated with visfatin (100 ng/ml) in the presence or absence of the PI3K and MEK1/2 inhibitors wortmannin (Wort, 100 nmol/L) and U0126 (10 μmol/L), respectively. Visfatin reduces the percentage cardiomyocyte death elicited by hypoxia-reoxygenation injury, and this cardioprotective effect is abolished in the presence of the kinase inhibitors. n > 200 cells per group. *P < 0.05.